Health and Fitness

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

Influenza Virus
3D print of influenza virus. The virus surface (yellow) is covered with proteins called hemagglutinin (blue) and neuraminidase (red). (Source: NIH)

NIH-supported Phase 1 trial of potential broadly protective vaccine.

Bethesda, Maryland—(ENEWSPF)—September 18, 2018
Contact: Anne A. Oplinger

An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit(VTEU) site…

Proud member of LION Publishers

Most read stories this week

Take a Survey

ARCHIVES